BioSpectrum India Magazine
BioSpectrum India Magazine

BioSpectrum India Magazine

This is an e-magazine. Download App & Read offline on any device.

Preview

Industry 4.0 journey of 10 innovative healthtech startups  

As we enter the Fourth Industrial Revolution, rapid technological advances are blurring the boundaries between the physical, digital and biological worlds. Indian life sciences companies have started taking small, experimental steps on their 4.0 journey. New technologies such as robotics, blockchain, 3D printing, machine learning (ML) and artificial intelligence (AI), and scientific breakthroughs such as gene editing, gene therapy is gradually resulting in a hyper-connected world and the transformation of life sciences companies’ business models. On the occasion of the World Health Day, BioSpectrum brings to you a list of 10 innovative healthtech startups who have started on with their 4.0 journey and are all set to transform the healthcare sector.

The BioSpectrum India edition was launched in March 2003 and is India's first comprehensive biotech business monthly magazine. It provides comprehensive coverage of the exciting happenings in life sciences, which include BioPharma, BioAgriculture, BioInformatics, BioIndustrial, BioSuppliers and BioServices and show cases the emerging Indian entrepreneurships in biotech industry. In a short time BioSpectrum has emerged as the most preferred platform to engage the life sciences industry in India and Asia Pacific. It is also widely accepted by research and academia community. Top key policy makers in the Central and state government use the magazine as a platform to reach out the Indian Biotech Industry. BioSpectrum has columns by Indian's top policy makers, biotechnology professionals, scientists and NGOs. Readers of BioSpectrum are from among the key Policy Makers, Key Executives and the Influencer's in Biotechnology, Pharmaceutical Companies, Research Heads of Clinical Research, Clinical Trials and Contract Mfg Organizations, Educational Institutes, Consultants, Fund Managers etc

Previous Issues